State Ledger
Company profile

CNS Pharmaceuticals, Inc. CIK 1729427

Ticker
CNSP (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Houston, TX 77027
Fiscal year end
2025 (FY)
Market Data
Close
$5.45
Change
+$0.00
Change %
0.00%
Volume
0

CNSP · trading date Oct 8, 2026 · previous close $5.45 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$15.85M
Total assets
$8.62M
Total liabilities
$4.10M
Stockholders' equity
$4.52M
Cash & equivalents
$7.20M
Operating income
-$15.99M
Operating cash flow
-$13.81M
Capital expenditures
$18.2K

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$13.83M
Free cash flow margin
—
Liabilities / assets
47.6%
Equity / assets
52.4%
CapEx / revenue
—
Operating cash flow / net income
0.87×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$15.85M $8.62M $4.10M $4.52M
2024 — -$14.86M $8.70M $2.52M $6.18M
2023 — -$18.85M $1.70M $6.13M -$4.43M
2022 — -$15.27M $13.05M $4.92M $8.13M
2021 — -$14.50M $8.76M $2.59M $6.16M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form DEFA14A
2026-08-25
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Houston, TX 77027
2100 WEST LOOP SOUTH
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:58 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies